Desmopressin 0.2mgTablet
Urology & Nephrology

Desmopressin 0.2mg

Desmopressin Acetate

Synthetic vasopressin analog for nocturnal enuresis and central diabetes insipidus with enhanced antidiuretic potency and minimal vasopressor activity. Manufactured by Sun Pharma for endocrinology/urology export.

Strengths

0.1mg / 0.2mg

Packing

30 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Desmopressin Acetate 0.1mg / 0.2mg
Dosage Form
Tablet
Available Strengths
0.1mg / 0.2mg
Packing
30 tablets/strip
Route of Administration
Oral or sublingual
Dosage
Nocturnal enuresis: 0.2mg at bedtime; DI: 0.1-0.2mg two to three times daily; restrict fluid intake from 1 hour before to 8 hours after dosing
Indications
Nocturnal enuresis in children and adults, central diabetes insipidus, nocturia
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C
Shelf Life
36 months
Side Effects
Hyponatremia (potentially dangerous), headache, nausea, abdominal pain, nasal congestion (spray)
Precautions
Hyponatremia risk — restrict fluid intake; avoid in polydipsia or conditions predisposing to hyponatremia; monitor serum sodium; avoid in renal impairment; not for nephrogenic DI

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Dutasteride 0.5mgCapsule

Dutasteride 0.5mg

Dutasteride

Dual-isoform 5-alpha reductase inhibitor (types I and II) providing more complete DHT suppression than finasteride, leading to clinically significant prostate volume reduction and improved urinary flow in benign prostatic hyperplasia. Long-term therapy reduces the risk of acute urinary retention and the need for surgical intervention, with benefit becoming evident after 3-6 months of continuous treatment.

0.5mg
Solifenacin 5mgTablet

Solifenacin 5mg

Solifenacin Succinate

Selective M3 muscarinic receptor antagonist that reduces detrusor muscle overactivity, providing clinically meaningful reductions in urinary urgency episodes, voiding frequency, and urge incontinence. Once-daily dosing with a long half-life ensures consistent 24-hour bladder control, and the dose can be titrated from 5mg to 10mg based on individual response and tolerability.

5mg / 10mg
Potassium Citrate 1080mgTablet

Potassium Citrate 1080mg

Potassium Citrate

Extended-release urinary alkalinizer that raises urinary pH and citrate concentration to inhibit calcium oxalate and uric acid crystal formation, significantly reducing recurrence rates of nephrolithiasis. The wax-matrix formulation ensures sustained alkalinisation throughout the day, making compliance straightforward with twice or thrice daily dosing alongside meals.

5mEq / 10mEq / 1080mg

Need bulk pricing for Desmopressin 0.2mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote